Page last updated: 2024-10-24

bupivacaine and Autosomal Dominant Myotubular Myopathy

bupivacaine has been researched along with Autosomal Dominant Myotubular Myopathy in 1 studies

Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schmid, E1
Jöhr, M1
Berger, TM1

Other Studies

1 other study available for bupivacaine and Autosomal Dominant Myotubular Myopathy

ArticleYear
X-linked myotubular myopathy: anesthetic management for muscle biopsy.
    Paediatric anaesthesia, 2006, Volume: 16, Issue:2

    Topics: Anesthesia, Caudal; Anesthetics, Local; Biopsy; Bronchodilator Agents; Bupivacaine; Epinephrine; Fat

2006